New York, NY, October 27, 2015 — BBH Capital Partners, a private equity fund sponsored by Brown Brothers Harriman & Co. (BBH), is pleased to announce that Rolf A. Classon has been appointed as a Senior Advisor. In this capacity, Mr. Classon will actively be involved in sourcing, evaluating investments and providing post-investment value-added oversight to portfolio companies focused on medical devices, pharmaceutical products and outsourced services supporting the device and pharmaceutical industries. Mr. Classon has also been appointed as a member of Brown Brothers Harriman’s Healthcare Advisory Board, which supports BBH Private Banking.
“We are delighted to have Rolf join our investment team as a Senior Advisor,” said Ivan Pirzada, BBH Managing Director and Principal of BBH Capital Partners. “Rolf’s distinguished career has afforded him the opportunity to develop a unique perspective on the medical product and pharmaceutical industries, which will be invaluable as we seek to deploy capital in these important growth areas. A key differentiator for BBH Capital Partners is the ability to leverage BBH’s access to industry thought leaders like Rolf who have exceptional networks in their areas of industry expertise.”
From October 2002 until his retirement in July 2004, Mr. Classon was Chairman of the Executive Committee of Bayer HealthCare AG, a subsidiary of Bayer AG. He served as President of Bayer Diagnostics from 1995 to 2002 and as Executive Vice President of Bayer Diagnostics from 1991 to 1995. Prior to 1991, Mr. Classon held various management positions with Pharmacia Corporation. Mr. Classon currently serves as Chairman of the Board of Hill-Rom and served as interim CEO of Hillenbrand Industries from May 2005 to March 2006. He currently serves as Chairman of the Board of Directors of Tecan Group Ltd. and as a member of the Board of Directors of Fresenius Medical Care and Catalent. Among other board roles, Mr. Classon previously served as a director of Millipore Corporation and Non-Executive Chairman of Prometheus Laboratories and Swedish Orphan International until they were acquired. In addition, he served as Non-Executive Chairman of Auxilium Pharmaceuticals, which was acquired by Endo Pharmaceuticals in January 2015. Mr. Classon received his chemical engineering certificate from the Gothenburg School of Engineering and a business degree from the Gothenburg University.
“BBH’s investment track record in healthcare combined with its differentiated culture and flexible investment mandate made the firm a natural fit for me,” said Mr. Classon. “I look forward to leveraging my industry experience and relationships to seek investment opportunities for BBH Capital Partners and working with its management teams to execute on their growth plans.”
Jeff Meskin, Partner of BBH, Head of BBH Private Banking and Co-Manager of BBH Capital Partners, added, “BBH is fortunate to be able to attract senior executives of Rolf’s stature. He is a welcome addition to our Senior Advisor program supporting BBH Capital Partners as well as Private Banking’s Healthcare Advisory Board, which includes executives from a variety of healthcare segments, including medical devices, providers, HCIT, pharmaceuticals and outsourced services.”
About BBH Capital Partners
BBH Capital Partners (BBHCP), a private equity fund sponsored by Brown Brothers Harriman & Co., provides friendly capital solutions to profitable, growth-oriented middle market companies. BBHCP typically invests between $25 million and $75 million per platform investment and has the flexibility to act as a control or non-control investor. BBHCP’s capital is used to support a variety of transactions including management or leveraged buyouts, growth financings, recapitalizations (including dividend recapitalizations), buy-and-build strategies and acquisitions.
About Brown Brothers Harriman
BBH is a privately held financial institution that has been a thought leader and solutions provider for nearly 200 years. The firm serves individuals, families, businesses and institutions in its three business lines: Private Banking, Investment Management and Investor Services. In addition to the $25.6 billion in assets under management (AUM) in Private Banking, BBH Investment Management has $52.3 billion in AUM, and the Investor Services business has over $4 trillion in assets under custody.1 BBH’s culture of accountability fosters deep and lasting relationships built on commitment, adaptability and trust. The company is independent, selective and specialized by design.
BBH Private Banking’s mission is to be the preeminent provider of advice and capital to private business owners and people of substantial wealth to help them create, transition, preserve and grow their wealth. The firm serves both corporate and private clients in the following products and services: Private Wealth Management, Corporate Lending, Corporate Advisory and Private Equity.
BBH operates a global business with 18 locations, including Beijing, Boston, Charlotte, Chicago, Denver, Dublin, Grand Cayman, Hong Kong, Kraków, London, Luxembourg, Nashville, New Jersey, New York, Philadelphia, Tokyo, Wilmington and Zürich. For more information about Brown Brothers Harriman, please visit www.bbh.com.
BBH is a registered service mark of Brown Brothers Harriman & Co. in the United States and other countries.
1 Investment Management AUM includes $19.4 billion in assets managed on behalf of BBH’s Private Banking business. All figures as of 9/30/2015.